首页> 外文会议>International Congress on Coronary Artery Disease. >Plasma Adiponectin Lowering after left Ventricular Assist Device Implantation is Associated with 1-Month Survival in Patients with Advanced Heart Failure
【24h】

Plasma Adiponectin Lowering after left Ventricular Assist Device Implantation is Associated with 1-Month Survival in Patients with Advanced Heart Failure

机译:降低左心室辅助装置植入后降低血浆脂联素与晚期心力衰竭患者的1个月存活相关

获取原文

摘要

In advanced heart failure (HF) patients, high circulating levels of adiponectin, an adipokine known to mediate metabolic and anti-inflammatory effects in the heart, are associated to a negative outcome. In order to evaluate adiponectin as a possible prognostic biomarker, we investigated the effect of implantation of left ventricular assist devices (LVAD) on circulating adiponectin levels. Mechanical unloading of the failing myocardium by LVAD implant induced an early decrease of adiponectin plasma levels, mainly in survivor patients, suggesting that early monitoring of adiponectin may be a reliable tool for outcome prediction in LVAD recipients.
机译:在晚期心力衰竭(HF)患者中,脂肪素的高循环水平,一种众所周知的己二酸蛋白在心脏中介导代谢和抗炎作用,与负面结果相关。为了评估脂肪蛋白作为可能的预后生物标志物,我们研究了左心室辅助装置(LVAD)对循环脂联素水平的影响。通过LVAD植入物失败的心肌机械卸载诱导脂联素血浆水平的早期降低,主要是在幸存者患者中,表明早期监测脂联素可能是LVAD受体中的结果预测的可靠工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号